# Cauldron

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cauldron

- Industry: Biotechnology
- Headquarters: Australia
- Website: www.cauldronferm.com/
- Total disclosed funding: $27M
- Latest round: Series A (Mar 24, 2026)
- Investors on record: 7

## About

Based in Orange, Australia, and founded in 2023, Cauldron Ferm operates as a food production company that develops fermentation facilities that help in the development of new products and ingredients. The company was Co-founded by its CEO Michele Stansfield and David Kestenbaum (CFO). In March 2026, Cauldron raised USD 13.25 million in series A funding led by Main Sequence Ventures, with participation from Horizons Ventures, NGS Super, and SOSV.

The firm offers an alternative way to produce food, feed, and fiber. It offers industrial fermentation which is a bio-acceleration process that helps in scaling up fermentation prototypes to higher quantities. This process mitigates the climate change, product contamination, and supply chain issues risks. 

The company plans to use the March 2026 funding for expansion of continuous hyper-fermentation technology.

## Funding rounds

- Series A, Mar 24, 2026, $13M — NGS Super, SOSV, Horizons Ventures, Main Sequence Ventures
- Series A, Dec 21, 2023, $6.4M — In-Q-Tel, SOSV, Horizons Ventures, Main Sequence Ventures, Bartok International Limited
- Seed, Mar 10, 2023, $7M — Horizons Ventures, Main Sequence Ventures, University of NSW, Bartok International Limited

## Investors

- Horizons Ventures — Seed, Series A
- Main Sequence Ventures (https://capitalatlas.ai/funds/main-sequence-ventures) — Seed, Series A
- University of NSW — Seed
- Bartok International Limited — Seed, Series A
- In-Q-Tel (https://capitalatlas.ai/funds/in-q-tel) — Series A
- SOSV (https://capitalatlas.ai/funds/sosv) — Series A
- NGS Super — Series A